EP1158983A4 - Inhibitors of prenyl-protein transferase - Google Patents

Inhibitors of prenyl-protein transferase

Info

Publication number
EP1158983A4
EP1158983A4 EP00912117A EP00912117A EP1158983A4 EP 1158983 A4 EP1158983 A4 EP 1158983A4 EP 00912117 A EP00912117 A EP 00912117A EP 00912117 A EP00912117 A EP 00912117A EP 1158983 A4 EP1158983 A4 EP 1158983A4
Authority
EP
European Patent Office
Prior art keywords
prenyl
inhibitors
protein transferase
transferase
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00912117A
Other languages
German (de)
French (fr)
Other versions
EP1158983A1 (en
Inventor
William C Lumma Jr
John T Sisko
Anthony M Smith
Thomas J Tucker
Christopher J Dinsmore
Jeffrey M Bergman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1158983A1 publication Critical patent/EP1158983A1/en
Publication of EP1158983A4 publication Critical patent/EP1158983A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP00912117A 1999-03-03 2000-03-01 Inhibitors of prenyl-protein transferase Withdrawn EP1158983A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12277199P 1999-03-03 1999-03-03
US122771P 1999-03-03
US12725799P 1999-03-31 1999-03-31
US127257P 1999-03-31
PCT/US2000/005357 WO2000051612A1 (en) 1999-03-03 2000-03-01 Inhibitors of prenyl-protein transferase

Publications (2)

Publication Number Publication Date
EP1158983A1 EP1158983A1 (en) 2001-12-05
EP1158983A4 true EP1158983A4 (en) 2003-05-21

Family

ID=26820876

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00912117A Withdrawn EP1158983A4 (en) 1999-03-03 2000-03-01 Inhibitors of prenyl-protein transferase

Country Status (6)

Country Link
US (1) US6355643B1 (en)
EP (1) EP1158983A4 (en)
JP (1) JP2002538120A (en)
AU (1) AU3390000A (en)
CA (1) CA2362494A1 (en)
WO (1) WO2000051612A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2550667T3 (en) 2010-02-18 2015-11-11 Vtv Therapeutics Llc Phenylheteroaryl derivatives and methods of use thereof
WO2011153359A1 (en) 2010-06-04 2011-12-08 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
WO2015070367A1 (en) * 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
US20210008084A1 (en) 2017-10-16 2021-01-14 Tsinghua University Mevalonate pathway inhibitor and pharmaceutical composition thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3041341A (en) * 1962-06-26 Derivatives of piperazins
US4093726A (en) * 1976-12-02 1978-06-06 Abbott Laboratories N-(2-benzimidazolyl)-piperazines
US5292726A (en) * 1991-05-22 1994-03-08 Merck & Co., Inc. N,N-diacylpiperazines
WO1995000497A1 (en) * 1993-06-18 1995-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1996030343A1 (en) * 1995-03-29 1996-10-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637271A (en) * 1963-04-04 1900-01-01
US3285809A (en) * 1965-06-08 1966-11-15 Robert R Mod Process of controlling microbial activity
GB1143882A (en) * 1966-06-21
DE2718393C2 (en) 1977-04-26 1985-05-09 Schering AG, 1000 Berlin und 4709 Bergkamen Process for the preparation of hydroxyl-containing monoenamines suitable for prepolymers
JPS5182285A (en) * 1974-04-16 1976-07-19 Eisai Co Ltd Kinatsuorinkeikagobutsu no goseihoho
CS167767B1 (en) * 1974-04-25 1976-05-28
DE2448003A1 (en) * 1974-10-09 1976-04-15 Bayer Ag MEANS OF REGULATING PLANT GROWTH
US4456603A (en) * 1979-08-14 1984-06-26 Eisai Co., Ltd. Polyprenylcarboxylic acid amides useful for treating liver dysfunction
US4523014A (en) * 1983-01-17 1985-06-11 Usv Pharmaceutical Corporation Piperazines 1-hexyl-4(3-ketohexyl)
SE8304361D0 (en) 1983-08-10 1983-08-10 Ferrosan Ab NOVEL 1-ACYLPIPERAZINE DERIVATIVES NOVEL 1-ACYLPIPERAZINE DERIVATIVES
JPH0710620B2 (en) 1985-03-28 1995-02-08 株式会社リコー Two-color thermosensitive recording label
US4917896A (en) 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US4829065A (en) 1987-04-24 1989-05-09 Syntex Pharmaceuticals, Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
EP0441226A1 (en) * 1990-01-29 1991-08-14 J. URIACH & CIA. S.A. (cyanomethyl)pyridines useful as PAF antagonists
US5219856A (en) 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
US5348955A (en) 1993-06-22 1994-09-20 Merck & Co., Inc. N,N-diacylpiperazines
US5478934A (en) 1994-11-23 1995-12-26 Yuan; Jun Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands
US5856326A (en) 1995-03-29 1999-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP3038016B2 (en) 1995-04-07 2000-05-08 シェーリング コーポレイション Carbonyl piperazinyl and carbonyl piperidinyl compounds inhibiting farnesyl protein transferase
US5811241A (en) * 1995-09-13 1998-09-22 Cortech, Inc. Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones
EP0921801A1 (en) 1996-04-03 1999-06-16 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU741725B2 (en) 1997-08-27 2001-12-06 Merck & Co., Inc. Inhibitors of prenyl-protein transferase

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3041341A (en) * 1962-06-26 Derivatives of piperazins
US4093726A (en) * 1976-12-02 1978-06-06 Abbott Laboratories N-(2-benzimidazolyl)-piperazines
US5292726A (en) * 1991-05-22 1994-03-08 Merck & Co., Inc. N,N-diacylpiperazines
WO1995000497A1 (en) * 1993-06-18 1995-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1996030343A1 (en) * 1995-03-29 1996-10-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0051612A1 *

Also Published As

Publication number Publication date
EP1158983A1 (en) 2001-12-05
AU3390000A (en) 2000-09-21
WO2000051612A1 (en) 2000-09-08
CA2362494A1 (en) 2000-09-08
JP2002538120A (en) 2002-11-12
US6355643B1 (en) 2002-03-12

Similar Documents

Publication Publication Date Title
EP1087770A4 (en) Inhibitors of prenyl-protein transferase
EP1165082A4 (en) Inhibitors of prenyl-protein transferase
EP1165084A4 (en) Inhibitors of prenyl-protein transferases
EP1324985A4 (en) Inhibitors of prenyl-protein transferase
AU2001243158A1 (en) Inhibitors of prenyl-protein transferase
EP1091736A4 (en) Inhibitors of prenyl-protein transferase
EP1045844A4 (en) Inhibitors of farnesyl-protein transferase
AU7354900A (en) Inhibitors of prenyl-protein transferase
AU2001238217A1 (en) Inhibitors of prenyl-protein transferase
AU2477400A (en) Inhibitors of prenyl-protein transferase
AU2001247197A1 (en) Inhibitors of prenyl-protein transferase
EP1158982A4 (en) Inhibitors of prenyl-protein transferase
AU2001227757A1 (en) Inhibitors of prenyl-protein transferase
AU2001238424A8 (en) Inhibitors of prenyl-protein transferase
AU2274101A (en) Inhibitors of prenyl-protein transferase
EP1035852A4 (en) Inhibitors of farnesyl-protein transferase
EP1035850A4 (en) Inhibitors of farnesyl-protein transferase
AU2001230864A1 (en) Inhibitors of prenyl-protein transferase
AU2001229320A1 (en) Inhibitors of prenyl-protein transferase
EP1165013A4 (en) Inhibitors of prenyl-protein transferase
EP1035849A4 (en) Inhibitors of farnesyl-protein transferase
AU2001227756A1 (en) Inhibitors of prenyl-protein transferase
EP1158983A4 (en) Inhibitors of prenyl-protein transferase
AU2478500A (en) Inhibitors of prenyl-protein transferase
AU5144201A (en) Inhibitors of prenyl-protein transferase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011004

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20011004;LT PAYMENT 20011004;LV PAYMENT 20011004;MK PAYMENT 20011004;RO PAYMENT 20011004;SI PAYMENT 20011004

A4 Supplementary search report drawn up and despatched

Effective date: 20030404

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07D 233/54 B

Ipc: 7C 07D 295/16 B

Ipc: 7A 61P 31/14 B

Ipc: 7A 61P 13/12 B

Ipc: 7A 61K 31/496 B

Ipc: 7A 61P 35/00 B

Ipc: 7C 07D 243/08 B

Ipc: 7A 61P 9/10 B

Ipc: 7A 61P 27/02 B

Ipc: 7A 61K 31/495 A

Ipc: 7A 61K 31/551 B

Ipc: 7C 12N 9/99 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030621